Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Vertex Quietly Terminates a Small Phase II CF Trial September 11, 2017 ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017 MacroGenics Announces Registered Direct Offering Of Common Stock April 26, 2017
ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017
